Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001952718 | SCV002210140 | pathogenic | Hereditary nonpolyposis colorectal neoplasms | 2021-04-09 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Cys1241Metfs*34) in the MSH6 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MSH6 are known to be pathogenic (PMID: 18269114, 24362816). For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals with MSH6-related conditions. This variant is not present in population databases (ExAC no frequency). |
Ambry Genetics | RCV002344079 | SCV002623227 | pathogenic | Hereditary cancer-predisposing syndrome | 2020-08-19 | criteria provided, single submitter | clinical testing | The c.3720dupA pathogenic mutation, located in coding exon 8 of the MSH6 gene, results from a duplication of A at nucleotide position 3720, causing a translational frameshift with a predicted alternate stop codon (p.C1241Mfs*34). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |
Genetics and Molecular Pathology, |
RCV003447608 | SCV004175355 | pathogenic | Lynch syndrome 5 | 2022-06-27 | criteria provided, single submitter | clinical testing |